Phibro Animal Health (PAHC) Competitors $23.25 -0.84 (-3.49%) Closing price 04:00 PM EasternExtended Trading$23.24 -0.01 (-0.04%) As of 05:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PAHC vs. RYTM, KRYS, SRPT, PTCT, ACAD, CYTK, RNA, ZLAB, SWTX, and RAREShould you be buying Phibro Animal Health stock or one of its competitors? The main competitors of Phibro Animal Health include Rhythm Pharmaceuticals (RYTM), Krystal Biotech (KRYS), Sarepta Therapeutics (SRPT), PTC Therapeutics (PTCT), ACADIA Pharmaceuticals (ACAD), Cytokinetics (CYTK), Avidity Biosciences (RNA), Zai Lab (ZLAB), SpringWorks Therapeutics (SWTX), and Ultragenyx Pharmaceutical (RARE). These companies are all part of the "pharmaceutical products" industry. Phibro Animal Health vs. Rhythm Pharmaceuticals Krystal Biotech Sarepta Therapeutics PTC Therapeutics ACADIA Pharmaceuticals Cytokinetics Avidity Biosciences Zai Lab SpringWorks Therapeutics Ultragenyx Pharmaceutical Phibro Animal Health (NASDAQ:PAHC) and Rhythm Pharmaceuticals (NASDAQ:RYTM) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, dividends, institutional ownership, profitability, valuation and community ranking. Do insiders & institutionals have more ownership in PAHC or RYTM? 99.3% of Phibro Animal Health shares are owned by institutional investors. 50.1% of Phibro Animal Health shares are owned by insiders. Comparatively, 6.1% of Rhythm Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media favor PAHC or RYTM? In the previous week, Phibro Animal Health had 1 more articles in the media than Rhythm Pharmaceuticals. MarketBeat recorded 7 mentions for Phibro Animal Health and 6 mentions for Rhythm Pharmaceuticals. Phibro Animal Health's average media sentiment score of 1.57 beat Rhythm Pharmaceuticals' score of 1.22 indicating that Phibro Animal Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Phibro Animal Health 6 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Rhythm Pharmaceuticals 6 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, PAHC or RYTM? Phibro Animal Health has a beta of 0.62, indicating that its share price is 38% less volatile than the S&P 500. Comparatively, Rhythm Pharmaceuticals has a beta of 2.36, indicating that its share price is 136% more volatile than the S&P 500. Does the MarketBeat Community favor PAHC or RYTM? Phibro Animal Health received 7 more outperform votes than Rhythm Pharmaceuticals when rated by MarketBeat users. However, 68.13% of users gave Rhythm Pharmaceuticals an outperform vote while only 59.81% of users gave Phibro Animal Health an outperform vote. CompanyUnderperformOutperformPhibro Animal HealthOutperform Votes31759.81% Underperform Votes21340.19% Rhythm PharmaceuticalsOutperform Votes31068.13% Underperform Votes14531.87% Which has better earnings and valuation, PAHC or RYTM? Phibro Animal Health has higher revenue and earnings than Rhythm Pharmaceuticals. Rhythm Pharmaceuticals is trading at a lower price-to-earnings ratio than Phibro Animal Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPhibro Animal Health$1.19B0.79$2.42M$0.7829.81Rhythm Pharmaceuticals$136.86M29.01-$184.68M-$2.81-22.21 Do analysts rate PAHC or RYTM? Phibro Animal Health presently has a consensus price target of $20.00, suggesting a potential downside of 13.98%. Rhythm Pharmaceuticals has a consensus price target of $75.38, suggesting a potential upside of 20.79%. Given Rhythm Pharmaceuticals' stronger consensus rating and higher possible upside, analysts plainly believe Rhythm Pharmaceuticals is more favorable than Phibro Animal Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Phibro Animal Health 2 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50Rhythm Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 13 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is PAHC or RYTM more profitable? Phibro Animal Health has a net margin of 1.75% compared to Rhythm Pharmaceuticals' net margin of -230.07%. Phibro Animal Health's return on equity of 25.35% beat Rhythm Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Phibro Animal Health1.75% 25.35% 6.21% Rhythm Pharmaceuticals -230.07%-367.36%-77.47% SummaryPhibro Animal Health beats Rhythm Pharmaceuticals on 12 of the 18 factors compared between the two stocks. Get Phibro Animal Health News Delivered to You Automatically Sign up to receive the latest news and ratings for PAHC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PAHC vs. The Competition Export to ExcelMetricPhibro Animal HealthPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$942.42M$6.48B$5.35B$8.38BDividend Yield2.01%2.66%5.22%4.10%P/E Ratio48.448.9226.8419.71Price / Sales0.79250.96391.39116.98Price / Cash10.8765.8538.2534.62Price / Book3.826.466.794.50Net Income$2.42M$143.98M$3.23B$248.18M7 Day Performance-0.47%3.04%4.07%1.14%1 Month Performance40.65%7.44%12.52%15.20%1 Year Performance26.57%-2.46%16.83%6.56% Phibro Animal Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PAHCPhibro Animal Health3.5291 of 5 stars$23.25-3.5%$20.00-14.0%+32.1%$942.42M$1.19B48.441,860Positive NewsRYTMRhythm Pharmaceuticals3.9119 of 5 stars$61.25+2.2%$75.38+23.1%+63.9%$3.90B$136.86M-14.15140Positive NewsKRYSKrystal Biotech4.8856 of 5 stars$132.29+1.3%$211.13+59.6%-20.0%$3.82B$333.45M44.24210SRPTSarepta Therapeutics4.8318 of 5 stars$37.94+4.1%$124.36+227.8%-69.4%$3.73B$2.23B30.35840Positive NewsAnalyst ForecastGap UpHigh Trading VolumePTCTPTC Therapeutics4.1851 of 5 stars$46.96+2.1%$61.92+31.9%+17.6%$3.72B$1.77B-7.911,410ACADACADIA Pharmaceuticals3.2836 of 5 stars$21.99-1.2%$25.42+15.6%+43.6%$3.68B$996.28M28.19510Trending NewsAnalyst ForecastAnalyst RevisionGap UpHigh Trading VolumeCYTKCytokinetics4.1484 of 5 stars$30.75-0.8%$74.44+142.1%-46.1%$3.67B$19.22M-5.72250RNAAvidity Biosciences1.908 of 5 stars$30.22-0.4%$66.38+119.7%+8.2%$3.64B$8.93M-10.49190Options VolumeZLABZai Lab2.6348 of 5 stars$32.99+6.7%$47.37+43.6%+56.6%$3.64B$418.33M-11.911,950SWTXSpringWorks Therapeutics2.3615 of 5 stars$46.27+0.3%$52.57+13.6%+9.1%$3.49B$219.67M-13.30230Positive NewsRAREUltragenyx Pharmaceutical3.9661 of 5 stars$36.19+1.6%$90.93+151.3%-10.1%$3.42B$590.69M-5.711,310Positive News Related Companies and Tools Related Companies RYTM Competitors KRYS Competitors SRPT Competitors PTCT Competitors ACAD Competitors CYTK Competitors RNA Competitors ZLAB Competitors SWTX Competitors RARE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PAHC) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phibro Animal Health Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Phibro Animal Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PAHC Stock Free PAHC Stock Alerts